{"id":"https://openalex.org/W1920959554","doi":"https://doi.org/10.1176/ajp.156.3.419","title":"Placebo-Controlled Study of the D4/5-HT2A Antagonist Fananserin in the Treatment of Schizophrenia","display_name":"Placebo-Controlled Study of the D4/5-HT2A Antagonist Fananserin in the Treatment of Schizophrenia","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W1920959554","doi":"https://doi.org/10.1176/ajp.156.3.419","mag":"1920959554","pmid":"https://pubmed.ncbi.nlm.nih.gov/10080558"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.156.3.419","doi":"https://doi.org/10.1176/ajp.156.3.419","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.156.3.419","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1920959554"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038386365","display_name":"Philippe Truffinet","orcid":"https://orcid.org/0000-0002-5895-9981","observed_orcids":["https://orcid.org/0000-0002-5895-9981"]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Truffinet","raw_affiliation_strings":["CNS Department, Rh\u00f4ne-Poulenc Rorer Research and Development, Antony, France. philippe.truffinet@rp-rorer.fr","Sanofi\u2013Aventis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNS Department, Rh\u00f4ne-Poulenc Rorer Research and Development, Antony, France. philippe.truffinet@rp-rorer.fr","institution_ids":[]},{"raw_affiliation_string":"Sanofi\u2013Aventis","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023252875","display_name":"Carol A. Tamminga","orcid":"https://orcid.org/0000-0002-6366-5697","observed_orcids":["https://orcid.org/0000-0002-6366-5697"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol A. Tamminga","raw_affiliation_strings":["Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110244081","display_name":"Louis F. Fabre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Louis F. Fabre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108104383","display_name":"Herbert Y. Meltzer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert Y. Meltzer","raw_affiliation_strings":["Psychiatry and Behavioral Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry and Behavioral Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112154985","display_name":"Marie-Emmanuelle Rivi\u00ef\u00bf \u2044 re","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie-Emmanuelle Rivi\u00ef\u00bf\u00bdre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5096888229","display_name":"Catherine Papillon-Downey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Papillon-Downey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.4009,"has_fulltext":false,"cited_by_count":103,"citation_normalized_percentile":{"value":0.95937592,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"156","issue":"3","first_page":"419","last_page":"425"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8460000157356262},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/paranoid-schizophrenia","display_name":"paranoid schizophrenia","score":0.7580000162124634},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.8029999732971191},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8270000219345093}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7494582533836365},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6619066596031189},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.6422181725502014},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6408294439315796},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4932071566581726},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.4471639394760132},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4466193914413452},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.3366325795650482},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.32186099886894226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3192247748374939},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.19739976525306702},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13881289958953857},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003499","descriptor_name":"Cyclic S-Oxides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1176/ajp.156.3.419","doi":"https://doi.org/10.1176/ajp.156.3.419","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.156.3.419","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:10080558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10080558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W83357382","https://openalex.org/W122505910","https://openalex.org/W153750880","https://openalex.org/W1998900400","https://openalex.org/W2003790404","https://openalex.org/W2022151784","https://openalex.org/W2035249679","https://openalex.org/W2059230444","https://openalex.org/W2079552625","https://openalex.org/W2086896242","https://openalex.org/W2094417837","https://openalex.org/W2100828552","https://openalex.org/W2109865728","https://openalex.org/W2131083220","https://openalex.org/W2146438680","https://openalex.org/W2165379748","https://openalex.org/W2401206973","https://openalex.org/W2402363043","https://openalex.org/W2463904389"],"related_works":["https://openalex.org/W2399594908","https://openalex.org/W1997023267","https://openalex.org/W2017096529","https://openalex.org/W2090329639","https://openalex.org/W2025004941","https://openalex.org/W2144513312","https://openalex.org/W2106156723","https://openalex.org/W4319456303","https://openalex.org/W2050774782","https://openalex.org/W3028442952"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,67,80,121,187,207,218],"authors'":[2],"objective":[3],"was":[4,32,71,93,100,210],"to":[5],"assess":[6],"the":[7,17,54,72,85,130,144,147,167,195,198,226],"potential":[8],"efficacy":[9],"of":[10,25,38,53,105,109,116,129,140,146,215,220],"fananserin":[11,39,112,133,201],"(RP62203),":[12],"a":[13,138,229],"potent":[14],"antagonist":[15,232],"at":[16,91,135],"D4":[18,231],"and":[19,75,87,113,124,172,180],"serotonin2A":[20],"(5-HT2A)":[21],"receptors,":[22],"on":[23,84,162],"symptoms":[24,190],"schizophrenia.":[26],"METHOD:":[27],"A":[28,96],"double-blind,":[29],"placebo-controlled":[30],"study":[31,222],"conducted":[33],"in":[34,102,205,212],"97":[35],"patients.":[36,216],"Doses":[37],"reached":[40],"250":[41],"mg":[42],"b.i.d.":[43],"over":[44],"28":[45],"days,":[46],"starting":[47],"with":[48,58,234],"an":[49,203,240],"8-day":[50],"escalation.":[51],"Most":[52],"patients":[55,106,131,148,199],"were":[56,62,160],"men":[57],"paranoid":[59],"schizophrenia;":[60],"they":[61],"approximately":[63],"38":[64],"years":[65],"old.":[66],"primary":[68],"outcome":[69],"measure":[70],"total":[73,122,185],"Positive":[74,86,123,171],"Negative":[76,88,125,173],"Syndrome":[77,89,126,174],"Scale":[78,90,127,175,184],"score.":[79,186],"patients'":[81,188],"mean":[82,139],"score":[83,128,145],"entry":[92],"91.8":[94],"(SD=16.5).":[95],"low":[97],"dropout":[98],"rate":[99],"observed":[101],"both":[103,213],"groups":[104,214],"(19":[107],"[30%]":[108],"those":[110,117],"given":[111,118,132,149,200],"nine":[114],"[27%]":[115],"placebo).":[119],"RESULTS:":[120],"decreased":[134,151],"endpoint":[136],"by":[137,152],"4.2":[141],"points":[142,154],"(SD=15.4);":[143],"placebo":[150],"6.7":[153],"(SD=19.6).":[155],"No":[156],"differences":[157],"between":[158],"treatments":[159],"found":[161],"secondary":[163],"measures":[164],"such":[165],"as":[166],"Clinical":[168],"Global":[169],"Impression,":[170],"subscores":[176],"or":[177],"individual":[178],"items,":[179],"Brief":[181],"Psychiatric":[182],"Rating":[183],"extrapyramidal":[189],"did":[191],"not":[192,224],"worsen":[193],"during":[194],"trial,":[196],"but":[197],"had":[202],"increase":[204],"akathisia.":[206],"safety":[208],"profile":[209],"good":[211],"CONCLUSIONS:":[217],"results":[219],"this":[221],"do":[223],"support":[225],"prediction":[227],"that":[228],"selective":[230],"associated":[233],"strong":[235],"5-HT2A":[236],"antagonism":[237],"will":[238],"exhibit":[239],"antipsychotic":[241],"effect.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1920959554","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
